EP2736908 - BICYCLIC PYRIMIDONE COMPOUNDS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 21.10.2016 Database last updated on 20.07.2024 | Most recent event Tooltip | 21.10.2016 | Application deemed to be withdrawn | published on 23.11.2016 [2016/47] | Applicant(s) | For all designated states Glaxo Group Limited 980 Great West Road Brentford Middlesex TW8 9GS / GB | [2014/23] | Inventor(s) | 01 /
WAN, Zehong GlaxoSmithKline (China) R&D Co. Ltd. Building 3 898 Halei Road Zhangjiang Hi-Tech Park Shanghai 201203 / CN | 02 /
LONG, Kai GlaxoSmithKline (China) R&D Co. Ltd. Building 3 898 Halei Road Zhangjiang Hi-Tech Park Shanghai 201203 / CN | 03 /
ZHANG, Xiaomin GlaxoSmithKline (China) R&D Co. Ltd. Building 3 898 Halei Road Zhangjiang Hi-Tech Park Shanghai 201203 / CN | 04 /
YU, Haihua GlaxoSmithKline (China) R&D Co. Ltd. Building 3 898 Halei Road Zhangjiang Hi-Tech Park Shanghai 201203 / CN | [2014/23] | Representative(s) | Jewson, Rie GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [2014/23] | Application number, filing date | 12738465.9 | 25.07.2012 | WO2012EP64598 | Priority number, date | WO2011CN77702 | 27.07.2011 Original published format: PCT/CN2011/077702 | [2014/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013014185 | Date: | 31.01.2013 | Language: | EN | [2013/05] | Type: | A1 Application with search report | No.: | EP2736908 | Date: | 04.06.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 31.01.2013 takes the place of the publication of the European patent application. | [2014/23] | Search report(s) | International search report - published on: | EP | 31.01.2013 | Classification | IPC: | C07D487/04, A61K31/519, A61P25/28 | [2014/23] | CPC: |
C07D487/04 (EP,US);
A61P25/00 (EP);
A61P25/28 (EP);
A61P3/06 (EP);
A61P9/10 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/23] | Extension states | BA | 04.02.2014 | ME | 04.02.2014 | Title | German: | BICYCLISCHE PYRIMIDONVERBINDUNGEN | [2014/23] | English: | BICYCLIC PYRIMIDONE COMPOUNDS | [2014/23] | French: | COMPOSÉS PYRIMIDONES BICYCLIQUES | [2014/23] | Entry into regional phase | 04.02.2014 | National basic fee paid | 04.02.2014 | Designation fee(s) paid | 04.02.2014 | Examination fee paid | Examination procedure | deleted | Communication of intention to grant the patent | 04.02.2014 | Amendment by applicant (claims and/or description) | 04.02.2014 | Examination requested [2014/23] | 02.02.2016 | Despatch of a communication from the examining division (Time limit: M04) | 14.06.2016 | Application deemed to be withdrawn, date of legal effect [2016/47] | 11.07.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/47] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 02.02.2016 | Fees paid | Renewal fee | 08.07.2014 | Renewal fee patent year 03 | 09.07.2015 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.07.2016 | 05   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO03087088 (GLAXO GROUP LTD [GB], et al) [AD] 1-19 * See the examples *; | [AD]WO2008048867 (GLAXO GROUP LTD [US], et al) [AD] 1-19 * claim 1 * | by applicant | WO9613484 | WO9619451 | WO9702242 | WO9712963 | WO9721675 | WO9721676 | WO9741098 | WO9741099 | WO9924420 | WO0010980 | WO0066566 | WO0066567 | WO0068208 | WO0160805 | WO0230904 | WO0230911 | WO03015786 | WO03016287 | WO03041712 | WO03042179 | WO03042206 | WO03042218 | WO03086400 | WO03087088 | WO2008048867 | US2008103156 | US2008090851 | US2008090852 | WO2008048866 | WO2005003118 | CA2530816 | WO2006063811 | WO2006063813 | WO2008141176 | JP2001088847 | US2008279846 | US2010239565 | US2008280829 | WO9702037 | WO9828310 | WO9828311 | WO9828312 | - ZALEWSKI A ET AL., ARTERIOSCLER. THROMB. VASC. BIOL., (2005), vol. 25, no. 5, pages 923 - 31 | - WILENSKY ET AL., CURRENT OPINION IN LIPIDOLOGY, (2009), vol. 20, pages 415 - 420 | - WILENSKY ET AL., NATURE MEDICINE, (2008), vol. 10, pages 1015 - 1016 | - VAN OIJEN ET AL., ANNALS OF NEUROLOGY, (2006), vol. 59, page 139 | - KASSNER ET AL., CURRENT ALZHEIMER RESEARCH, (2008), vol. 5, pages 358 - 366 | - DILDAR ET AL., ALZHEIMER DIS ASSOC DISORD, (201004), vol. 24 | - SINEM ET AL., CURRENT ALZHEIMER RESEARCH, (2010), vol. 7, pages 463 - 469 | - COLANGELO ET AL., JOURNAL OF NEUROSCIENCE RESEARCH, (2002), vol. 70, pages 462 - 473 | - WYSS-CORAY, NATURE MEDICINE, (200609), vol. 12 | - SHI ET AL., ATHEROSCLEROSIS, (2007), vol. 191, pages 54 - 62 | - PERRY, ACTA NEUROPATHOL, (2010), vol. 120, pages 277 - 286 | - BUSCHINI ET AL., PROGRESS IN NEUROBIOLOGY, (2011), vol. 95, pages 14 - 25 | - TEZEL, Progress in Brain Research, vol. 173 | - BERGE ET AL., J. PHARM, SCI., (1977), vol. 66, pages 1 - 19 | - P L GOULD, INTERNATIONAL JOURNAL OF PHARMACEUTICS, (1986), vol. 33, pages 201 - 217 | - BIGHLEY ET AL., Encyclopedia of Pharmaceutical Technology, MARCEL DEKKER INC, (1996), vol. 13, pages 453 - 497 | - MARTINEZ FO ET AL., J IMMUNOL, (2006), vol. 177, pages 7303 - 7311 | - LAMB J ET AL., SCIENCE, (2006), vol. 313, pages 1929 - 1935 | - Remington's Pharmaceutical Sciences, MACK PUBLISHING COMPANY | - The Handbook of Pharmaceutical Additives, GOWER PUBLISHING LIMITED | - The Handbook of Pharmaceutical Excipients, AMERICAN PHARMACEUTICAL ASSOCIATION AND THE PHARMACEUTICAL PRESS | WO2011CN01597 |